SEC Form D · filed May 31, 2019
INNOVATE BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Arnar Agnarsson · Bozeman, MTDirectorAnthony E. Maida Iii · Raleigh, NCDirectorJay P. Madan · Raleigh, NCExec · DirectorSaira K. Ramasastry · Raleigh, NCDirectorLorne Thomas · Odessa, FLExec · DirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorChristopher Long · Mission Woods, KSDirectorLorin K. Johnson · Raleigh, NCDirectorScott Zeilinger · New York, NYExec · DirectorAnthony E. Maida Iii · Raleigh, NCDirectorJohn Bykowski · Hayward, CAExec · DirectorWilliam P. Corry · Sewickley, PADirectorRoy K. Proujansky · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorJeffrey Myers · New York, NYDirectorKevin Cavenaugh · Portland, ORExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗